Barrett's esophagus (BE) is a premalignant condition in which the normal squamous cell
lining of the esophagus is replaced by columnar epithelium containing specialized intestinal …

Barrett's esophagus (BE) is defined as a metaplastic change in the normal esophageal
squamous epithelium to an intestinalized columnar epithelium, likely in response to chronic …

Despite the presence of Barrett's esophagus (BE) in 1% to 2% of the US population, its
association with progression to esophageal adenocarcinoma, and a 500% increase in the …

Since its introduction as a therapeutic tool to ablate Barrett's esophagus, radiofrequency
ablation (RFA) has been studied in a number of influential clinical trials. 1–4 Over the past 5 …

BACKGROUND & AIMS: Patients with Barrett's esophagus (BE) and high-grade dysplasia
(HGD) or early neoplasia increasingly receive endoscopic mucosal resection and …

BACKGROUND & AIMS: The goal of radiofrequency ablation (RFA) for patients with Barrett's
esophagus (BE) is to eliminate dysplasia and metaplasia. The efficacy and safety of RFA for …

Radiofrequency ablation (RFA) is a safe and effective thermal ablative therapy for dysplastic
Barrett's esophagus (BE) and, to a lesser extent, nondysplastic BE. Before the utilization of …

Results: Of 60 eligible patients, 50 consented to participate. Of 1473 esophageal specimens
obtained at 5 years 85% contained lamina propria or deeper tissue (per patient, mean 30 …

There is increasing interest in the endoscopic treatment of Barrett's esophagus. Endoscopic
treatment has been utilized for many years, but in the past, no specific method has emerged …

Barrett's esophagus is a condition in which the normal squamous lining of the esophagus
has been replaced by columnar epithelium containing intestinal metaplasia induced by …